Word

VIVITIDE

Status

Registered

Status Code

700

Status Date

Tuesday, July 6, 2021

Serial Number

88906697

Registration Number

6412529

Registration Date

Tuesday, July 6, 2021

Mark Type

4000

Filing Date

Friday, May 8, 2020

Published for Opposition

Tuesday, November 17, 2020

Trademark Owner History

BIOSYNTH INTERNATIONAL, INC. -
VIVITIDE, INC. - Original Registrant
Peptide Acquisition, Inc. - Owner At Publication

Classifications

40 Custom manufacture of peptides and antibodies for research institutions and pharmaceutical companies

5 Chemical preparations for pharmaceutical or medical purposes, namely, for preventing or treating Alzheimer's disease, acromegaly, cancer, coronary syndromes, diabetes, diseases of the intestines, endometriosis, erectile dysfunction, glaucoma, growth hormone deficiency, hypoglycemia, myocardial infarction, Parkinson's disease, neurological diseases, rheumatic diseases, microbial diseases, virus infections and skin diseases; Diagnostic preparations for medical or veterinary purposes; Pharmaceutical preparations for preventing or treating Alzheimer's disease, acromegaly, cancer, coronary syndromes, diabetes, diseases of the intestines, endometriosis, erectile dysfunction, glaucoma, growth hormone deficiency, hypoglycemia, myocardial infarction, Parkinson's disease, neurological diseases, rheumatic diseases, microbial diseases, virus infections and skin diseases; vaccines

35 Distributorship services in the field of catalog and custom peptides, amino acid derivatives, enzymes, substrates and antibodies; Catalog ordering service featuring peptides, amino acid derivatives, enzymes, substrates and antibodies for research institutions and pharmaceutical companies

1 Biochemicals, chemical preparations and diagnostic preparations for in vitro and in vivo use in scientific and laboratory research and development, namely, amino acids, amino acid derivatives, antibodies, cytokines, enzyme inhibitors and substrates, growth factors, peptides, reagents for peptide synthesis, and recombinant proteins; chemical additives for use in the manufacture of pharmaceuticals

42 Consulting, research, development and analytical services in the field of pharmaceutical development; custom design and development of peptides and antibodies for research institutions and pharmaceutical companies

VIVITIDE

Trademark Events

Aug 16, 2023

Teas Change Of Correspondence Received

Aug 16, 2023

Attorney/Dom.Rep.Revoked And/Or Appointed

Aug 16, 2023

Teas Revoke/App/Change Addr Of Atty/Dom Rep Received

Aug 16, 2023

Applicant/Correspondence Changes (Non-Responsive) Entered

Aug 16, 2023

Teas Change Of Owner Address Received

Aug 9, 2023

Automatic Update Of Assignment Of Ownership

Jul 26, 2023

Assignment Of Ownership Not Updated Automatically

Dec 7, 2022

Assignment Of Ownership Not Updated Automatically

Jul 6, 2021

Registered-Principal Register

May 29, 2021

Notice Of Acceptance Of Statement Of Use E-Mailed

May 28, 2021

Allowed Principal Register - Sou Accepted

May 27, 2021

Statement Of Use Processing Complete

May 17, 2021

Use Amendment Filed

May 27, 2021

Case Assigned To Intent To Use Paralegal

May 17, 2021

Teas Statement Of Use Received

Feb 3, 2021

Automatic Update Of Assignment Of Ownership

Jan 12, 2021

Noa E-Mailed - Sou Required From Applicant

Nov 17, 2020

Official Gazette Publication Confirmation E-Mailed

Nov 17, 2020

Published For Opposition

Oct 28, 2020

Notification Of Notice Of Publication E-Mailed

Oct 5, 2020

Approved For Pub - Principal Register

Sep 4, 2020

Teas/Email Correspondence Entered

Sep 3, 2020

Correspondence Received In Law Office

Sep 3, 2020

Teas Response To Office Action Received

Aug 12, 2020

Notification Of Non-Final Action E-Mailed

Aug 12, 2020

Non-Final Action E-Mailed

Aug 12, 2020

Non-Final Action Written

Aug 5, 2020

Assigned To Examiner

May 19, 2020

New Application Office Supplied Data Entered

May 12, 2020

New Application Entered